Skip to main content
Premium Trial:

Request an Annual Quote

European Vascular Genomics Network Begins Operations

NEW YORK, May 12 (GenomeWeb News) - The European Vascular Genomics Network -- a European Union-funded initiative under the 6th Framework for technology research and development -- began operations this week, Inserm, the French National Institute of Health and Medical Research announced.


The network of excellence, fueled with €59 million ($70 million) funding with €9 million provided by the EU over five years, includes some 25 basic and clinical institutions, two biotechnology companies, and one management company from 10 EU member or associated states. Alain Tedgui of Inserm is the network coordinator. (Click here for a list of the participants).


The research activities of EVGN will concentrate research on three areas of cardiovascular disease and therapy:  endothelial dysfunction in the development of atherosclerosis; the instability of the atherosclerotic plaque at the root of arterial thrombus formation; and therapeutic angiogenesis.


The organization plans a series of workshops, starting with the "Genomics and Proteomics of Plaque Instability," on Friday, May 14, at the Sheraton Hotel at Amsterdam's Schiphol airport.



The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.